[1]方欢英,郭金虎,姜鹏飞,等.第四代电化学发光HIV筛查试剂在AIDS诊断中的应用探讨[J].中国皮肤性病学杂志,2020,(08):959-963.[doi:10.13735/j.cjdv.1001-7089.201910099]
 FANG Huanying,GUO Jinhu,JIANG Pengfei,et al.Value of the Fourth Generation Electrochemiluminescence HIV Screening Reagent in the Diagnosis of Acquired Immunodeficiency Syndrome(AIDS)[J].The Chinese Journal of Dermatovenereology,2020,(08):959-963.[doi:10.13735/j.cjdv.1001-7089.201910099]
点击复制

第四代电化学发光HIV筛查试剂在AIDS诊断中的应用探讨
分享到:

《中国皮肤性病学杂志》[ISSN:1001-7089/CN:61-1197/R]

卷:
期数:
2020年08期
页码:
959-963
栏目:
检验技术
出版日期:
2020-07-28

文章信息/Info

Title:
Value of the Fourth Generation Electrochemiluminescence HIV Screening Reagent in the Diagnosis of Acquired Immunodeficiency Syndrome(AIDS)
文章编号:
1001-7089(2020)08-0959-05
作者:
方欢英郭金虎姜鹏飞杨术生
同济大学附属东方医院检验科,上海200123
Author(s):
FANG HuanyingGUO JinhuJIANG PengfeiYANG Shusheng
(Department of Laboratory Medcine,Shanghai East Hospital,Tongji University School of Medicine,Shanghai 200123,China)
关键词:
人类免疫缺陷病毒 电化学发光免疫分析 免疫印迹试验
Keywords:
Human immunodeficiency virus Electrochemiluminescence immunoassay Western blot
分类号:
R 512.91
DOI:
10.13735/j.cjdv.1001-7089.201910099
文献标志码:
B
摘要:
目的 对比人类免疫缺陷病毒(HIV)抗体第四代电化学发光免疫分析(ECLIA)试剂筛查结果与免疫印迹试验(WB)结果,评估ECLIA法HIV筛查在艾滋病诊断中的临床价值。方法 ECLIA法对2016年1月-2019年8月本院109 649例患者进行HIV抗体初筛检测,复核阳性标本用WB法确证,记录结果并进行对比分析。结果 ECLIA 法初筛阳性217例,WB确证阳性 45例,ECLIA初筛方法确证阳性率为20.74%。WB确证阳性患者ECLIA法S/CO值为367.70(160.60,790.80),与确证阴性患者S/CO值[2.1(1.45,3.96)]和确证不确定患者S/CO值[1.84(1.31,3.83)]差异有统计学意义(P<0.05)。比较1<S/CO≤10、10<S/CO≤50及S/CO >50三组,WB法获得的阳性率的差异有统计学意义(P<0.05)。结论 ECLIA法筛查HIV抗体灵敏度较高,但存在较高的假阳性率,尤其是低S/CO值的标本。较高的S/CO值的患者HIV感染的风险较大,但是高S/CO值并不代表HIV感染,应进一步推进诊断试剂的研发和改进进程,助力临床精准医疗,减轻AIDS公共管理负担。
Abstract:
Objective To evaluate the clinical value of human immunodeficiency virus(HIV)antibody screening in the diagnosis of acquired immunodeficiency syndrome(AIDS)by comparing the fourth generation electrochemiluminescence immunoassay(ECLIA)results with those from Western blot(WB).Methods The 109 649 patients in our hospital from January 2016 to August 2019 were examined for HIV antibody by the fourth generation ECLIA method.The re-inspection of positive samples was confirmed by WB, the results were recorded and analyzed.Results There were 217 HIV-antibody preliminary screening positive samples totally,45 cases of which were confirmed positive by WB.The positive rate of ECLIA screening method was 20.74%.The S/CO value of ECLIA in WB positive patients was 367.70(160.60,790.80),which was significantly different from that of negative patients [2.1(1.45,3.96)] and uncertain patients [1.84(1.31,3.83)](P <0.05).The confirmed positive rate was statistically significant among 1<S/CO ≤10,10<S/CO≤50 and S/CO >50 groups(P < 0.05).Conclusion ECLIA for HIV-antibody screening has a high sensitivity,while the false positive rate is also high,especially in low S/CO value samples.Patients with higher S/CO value have a higher risk of HIV infection,but high S/CO value does not represent HIV infection.Therefore the diagnostic reagent development and improvement should be further accelerated to help clinically precise treatment and reduce the burden of AIDS in public health management.

参考文献/References:

[1] 中华医学会感染病学分会艾滋病丙型肝炎学组,中国疾病预防与控制中心.中国艾滋病诊疗指南(2018版)[J].中华传染病杂志,2018,36(12):705-724.
[2] Patel P,Mackellar D,Simmons P,et al.Detecting acute human immunodeficiency virus infection using 3 different screening immunoassays and nucleic acid amplification testing for human immunodeficiency virus RNA,2006-2008 [J].Arch Intern Med,2010,170(1):66-74.
[3] Weber B,Gtirtler L,Thorstensson R,et al.Multicenter evaluation of a new automated fourth-generation human immunodeficiency virus screening assay with a sensitive antigen detection module and high specificity [J].J Clin Microbiol,2002,40(6):1938-1946.
[4] WHO.WHO HIV update:global epidemic,progress in scale up and policy uptake [EB/OL].[2019-8-2].http://www.who.int/hiv/data/en/.
[5] WHO.Global scientific leaders explore strategies to achieve the 90-90-90 target [EB/OL].[2018-1-27].http://www.unaids.org/en/resources/presscentre/feature-stories /2015/July/20150722_90-90-90-target.
[6] Hollingsworth TD,Anderson RM,Fraser C.HIV-1 transmission,by stage of infection[J].J Infect Dis,2008,198(5):687-693.
[7] 许文燕,邱茂锋,佐合拉·吐尔地,等.第四代HIV抗原抗体酶联检测试剂缩短HIV检测窗口期的研究[J].中华检验医学杂志,2007,30(3):284-287.
[8] Delwart E,Slikas E,Stramer SL,et al.Genetic diversity of recently acquired and prevalent HIV,hepatitis B virus,and hepatitis C virus infections in US blood donors[J].J Infect Dis,2012,205(6):875-885.
[9] 李云春,钟利,王悦,等.类风湿性关节炎患者HIV抗体检测假阳性结果影响因素的分析[J].中华检验医学杂志,2016,39(7):522-525.
[10] 曾小妹,陈言,莫少雄,等.海南省2011-2015年艾滋病病例报告情况分析[J].中国皮肤性病学杂志,2019,32(10):1172-1176.
[11] 朱思远,李冬冬,王婷婷,等.中国西南地区2008-2013年HIV抗体检测结果与分析[J].中华实验和临床病毒学杂志,2015,29(4):335-337.
[12] Akl P,Blick KE.A case of false-positive test results in a pregnant woman of unknown HIV status at delivery [J].Lab Med,2014,45(3):259-263.
[13] Liu P,Jackson P,Shaw N,et al.Spectrum of false positivity for the fourth generation human immunodeficiency virus diagnostic tests[J].AIDS Res Ther,2016,13:1.
[14] 李楠,缪礼锋.WB带型分析对HIV感染期和AIDS期的诊断意义[J].疾病控制杂志,2005,9(4):376-377.
[15] Morris G,Reiche EMV,Murru A,et al.Multiple immune-inflammatory and oxidative and nitrosative stress pathways explain the Frequent Presence of Depression in Multiple Sclerosis[J].Mol Neurobiol,2018,55(8):6282-6306.
[16] 欧阳霖,张铁军,张颖华,等.HIV-1抗体阳性者WB带型及其在不同临床分期中的特征分析[J].复旦学报(医学版),2017,44(5):664-667.
[17] 周昀,杨新智,周秋颖,等.HIV抗体初筛阳性标本的复检与确证结果分析[J].沈阳医学院学报,2019,21(1):56-61.

相似文献/References:

[1]王军雄,陈倩倩,李水凤,等.以阴囊斑丘疹为主要表现的二期梅毒并HIV感染1例[J].中国皮肤性病学杂志,2016,(11):1152.[doi:10.13735/j.cjdv.1001-7089.201604119]
 WANG Jun-xiong,CHEN Qian-qian,LI Shui-feng,et al.A Case of Secondary Syphilis Merger HIV Infection Mainly Performed as Maculopapule on the Scrotum[J].The Chinese Journal of Dermatovenereology,2016,(08):1152.[doi:10.13735/j.cjdv.1001-7089.201604119]
[2]王袁,张树敬,蔡黎霞,等.肿瘤专科医院就诊患者HIV感染情况分析[J].中国皮肤性病学杂志,2017,(04):410.[doi:10.13735/j.cjdv.1001-7089.201610013]
 WANG Yuan,ZHANG Shu-jing,CAI Li-xia,et al.Prevalence and Analysis of HIV Infection in Tumor Patients in Cancer Hospital[J].The Chinese Journal of Dermatovenereology,2017,(08):410.[doi:10.13735/j.cjdv.1001-7089.201610013]
[3]黄敖,罗宏,张莲,等.5-氨基酮戊酸光动力疗法治疗尖锐湿疣合并HIV感染25例疗效观察[J].中国皮肤性病学杂志,2018,(06):733.[doi:10.13735/j.cjdv.1001-7089.201710070]
 HUANG Ao,LUO Hong,ZHANG Lian,et al.Effect of Photodynamic Therapy on Condyloma Acuminata Combined with HIV for 25 Patients[J].The Chinese Journal of Dermatovenereology,2018,(08):733.[doi:10.13735/j.cjdv.1001-7089.201710070]
[4]刘洋,刘毅,史丙俊,等.二期梅毒合并生殖器疱疹和HIV感染1例[J].中国皮肤性病学杂志,2013,(02):170.
[5]赵玉,刘媛媛.西安市某综合医院2007-2017年HIV感染监测结果分析[J].中国皮肤性病学杂志,2019,(07):800.[doi:10.13735/j.cjdv.1001-7089.201806055]
 ZHAO Yu,LIU Yuanyuan.Analysis of HIV Infection Surveillance in a General Hospital of Xi'an from 2007 to 2017[J].The Chinese Journal of Dermatovenereology,2019,(08):800.[doi:10.13735/j.cjdv.1001-7089.201806055]

备注/Memo

备注/Memo:
[基金项目] 上海市浦东新区卫生系统重点学科建设资助(PWZxk2017-09)
[作者单位] 同济大学附属东方医院检验科,上海200123
[通信作者] 杨术生,E-mail:fdxyz1981@163.com
[Corresponding author] YANG Shusheng,E-mail:fdxyz1981@163.com
更新日期/Last Update: 2020-07-28